- Record: found
- Abstract: not found
- Article: not found
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study
Michele I. Saunders ,
Peter J. Hoskin ,
Katherine Pigott ,
Melanie E.B. Powell ,
Kathleen Goodchild ,
Stan Dische ,
Juliana Denekamp ,
Michael R.L. Stratford ,
Madeleine F. Dennis ,
Ana Maria Rojas
November 1997
November 1997
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
ARCON (Accelerated Radiotherapy, CarbOgen, Nicotinamide) achieves a large therapeutic
gain in rodents. A phase I/II study was therefore undertaken to determine its feasibility
in patients with locally advanced head and neck cancer.